Femasys Inc

Name: Femasys Inc standardized financial statements, quarterly
Creator: Listed

FEMYNasdaqCIK 1339005HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$331.8k, Q2 FY2026

Operating income−$5.1m, Q2 FY2026

Net income−$4.5m, Q2 FY2026

Femasys Inc, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	244	213	271	221	555	582	341	409	729	813	425	332
Cost of revenue	$k	86.2	78.3	88.5	73.1	191	192	117	158	294	303	159	142
Gross profit	$k	158	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Research and development	$k	2,073	2,071	1,771	1,976	2,303	2,167	2,968	1,414	1,382	1,813	1,309	1,947
Operating income	$k	(4,081)	(4,450)	(3,463)	(4,482)	(5,118)	(4,723)	(5,461)	(3,852)	(3,654)	(4,623)	(4,224)	(5,066)
Interest expense	$k	8.0	155	362	388	413	440	459	492	532	408	177	186
Income tax	$k	0.0	4.3	0.0	(1.8)	1.2	10.2	(4.2)	0.0	0.0	5.5	0.0	0.9
Net income	$k	(3,997)	(4,410)	(3,600)	(4,685)	(5,409)	(5,124)	(5,897)	(4,586)	(4,195)	(3,950)	846	(4,469)
Diluted EPS	$ per share	(0.26)	not reported	(0.17)	(0.21)	(0.24)	not reported	(0.23)	(3.18)	(0.10)	not reported	0.00	(1.33)
Basic EPS	$ per share	(0.26)	not reported	(0.17)	(0.21)	(0.24)	not reported	(0.23)	(3.18)	(0.10)	not reported	0.00	(1.33)

Balance sheet

Cash and equivalents$1.4m, Q2 FY2026

Shareholders' equity$4.0m, Q2 FY2026

Femasys Inc, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	8.7	21.7	17.8	13.5	7.6	3.5	3.8	3.2	4.6	9.3	5.4	1.4
Current assets	$m	10.2	23.2	19.9	15.9	11.3	8.0	9.1	9.8	12.2	16.5	12.3	8.3
Total assets	$m	14.9	27.8	24.4	20.3	15.6	12.4	13.3	13.8	16.3	20.7	16.5	12.3
Current liabilities	$m	2.2	3.1	2.4	2.5	2.9	8.6	9.8	11.0	10.5	3.6	3.2	3.9
Total liabilities	$m	4.4	9.4	8.8	9.0	9.6	10.1	11.3	12.3	11.7	14.9	9.2	8.3
Shareholders' equity	$m	10.4	18.4	15.6	11.3	6.0	2.3	2.0	1.5	4.6	5.9	7.3	4.0

Cash flow

Operating cash flow−$3.9m, Q2 FY2026

Capital expenditure$9.4k, Q2 FY2026

Share repurchases$161.8k, Q1 FY2025

Femasys Inc, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(2,856)	(3,036)	(4,568)	(4,327)	(5,475)	(5,075)	(4,765)	(4,353)	(5,387)	(4,185)	(4,144)	(3,936)
Capital expenditure	$k	27.2	44.9	64.6	182	408	107	96.6	94.2	194	140	79.1	9.4
Share repurchases	$k	0.0	230	24.1	6.6	0.0	30.1	162	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)3.36m, Q2 FY2026

Femasys Inc, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	11.8	11.9	13.1	15.1	21.8	22.2	22.2	25.1	1.4	41.0	78.1	3.4

Shares outstanding: 8.38m at Aug 13, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.